Please login to the form below

Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018

Global healthcare communications agency, Havas Lynx, celebrated winning top honours as they collected three prestigious Cannes Lions awards alongside the highly coveted Cannes Lions Healthcare Agency of the Year 2018.

The Lions Health Awards are the most established and sought-after awards for the entire global creative and marketing communications industry. The trophies are recognised globally as the ultimate achievement in creativity and winners are regarded as the world’s best.

The evening started well for Havas Lynx as they picked up a Bronze award in Cinematography for ‘The Attack’, a tense and striking film metaphorically comparing the unbearable pain of a heart attack to a shark attack out at sea. The impactful film is designed to urge cardiologists to keep treating heart attack victims to reduce the risk of often fatal second heart attacks.

Havas Lynx then went on to pick up two Silver Lions. The first was in the Product Innovation category for Ouchie, a campaign designed to raise awareness and support children with JIA (Junior Idiopathic Arthritis). The second silver was in the Art Direction category for its inspired and inventive Attention Deficit Hyperactivity Disorder (ADHD) Rollercoaster campaign.

But the ultimate win came when Havas Lynx were named as Cannes Lions Healthcare Agency of the Year 2018. This prestigious award is given annually in recognition of the healthcare agency that obtains the most points across both wins and shortlisted entries. Havas Lynx’s 7 shortlists and 3 award wins across the healthcare categories pushed them into first place, crowning them as the overall winner.

The Cannes Lions International Festival of Creativity brings together professionals from across healthcare and pharma communications. Lions Health seeks to challenge norms and motivate change in these highly innovative yet fiercely regulated industries. From chief creative officers to digital medicine leaders, a host of experts examine the intersection of health, creativity and technology, and inspire the industry with fresh, forward-thinking ideas.

Commenting on the triple win and Agency of the Year 2018, Havas Lynx CCO, Tom Richards, said:

“This is momentous for Havas Lynx. To win three awards here was an amazing achievement, but then to go on and win Cannes Lions Healthcare Agency of the Year, was incredible. It is testament to the work and dedication of the whole team… we couldn’t be prouder. 

“Winning at Cannes is a defining moment for us, and it’s thanks to the continued dedication, determination and ambition of our team, and the extraordinary work of our clients, who trust us to communicate their healthcare innovations in a way which challenges and subverts industry expectations. 

“We take great pride in our work and we continually strive to create bold, highly creative and powerful work which resonates with both healthcare professionals, patients and caregivers to ultimately improve the future of healthcare and change lives for the better."

10th July 2018

Share

Tags

Company Details

HAVAS LYNX

+44 (0)161 228 7756

Contact Website

Address:
52 Princess Street
Manchester
M1 6JX

Latest content on this profile

Trio of Communiqué Awards for Havas Lynx
A global healthcare communications agency, with offices in Manchester, London and New York, is celebrating again after collecting a trio of titles at the Communiqué Awards.
HAVAS LYNX
Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018
Global healthcare communications agency, Havas Lynx, celebrated winning top honours as they collected three prestigious Cannes Lions awards alongside the highly coveted Cannes Lions Healthcare Agency of the Year 2018.
HAVAS LYNX
SWITCHED ONcology Patient Experience Focus Group Full Discussion
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In the patient experience focus group, the discussion focused on the patient journey from pre-diagnosis right through to treatment and support. The focus group provided deeper insight in to a number of themes including the transformation of cancer understanding, the barriers to cancer diagnosis, the advent of new treatments including immunotherapy, communication around treatment, access to information for both patients and hcps, patient support & wellbeing and the role of caregivers.
HAVAS LYNX
SWITCHED ONcology Patient Experience Focus Group Highlights
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We are at a time of fundamental change in our understanding around the disease - the way we access it, categorise it and the way we think about it. Has the language kept up? That's the question that I have." Vernon Bainton, Chief Medical Officer, Havas Lynx Group
HAVAS LYNX
SWITCHED ONcology
We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched ON. Switched ONcology is the latest thought leadership campaign from the award-winning Havas lynx portfolio. The campaign is designed to combine science, creativity and technology in the delivery of communications that better support healthcare professionals, carers and ultimately patients on their journey with cancer. The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into oncology.
HAVAS LYNX
The Big Communication - matching unprecedented clinical advances in immunotherapy with transformative communication
In this white paper, we explore the exciting new frontier of cancer treatment - immuno-oncology (IO) - and what it means for how we communicate with healthcare professionals, patients and carers. For those on the frontline of treating cancer, IO brings a whole new level of excitement and opportunity, but also unprecedented complexity and uncertainty. And for patients, the practicalities of cancer treatment have changed. In short, the fundamental realities of cancer has changed and communication has never had a more important a role to play.
HAVAS LYNX